The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Analytics · HPLC & UHPLC

What a reversed-phase purity number actually is

Solved
Solved by e.ferreira in post #5
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

Jump to the accepted answer →

N
NardoneTL2Member23 Jun 2026#1

The question in the title: What a reversed-phase purity number actually is I will give what I have already checked below so nobody repeats it.

I would like to understand what this number means before I repeat it anywhere.

A PeptideMeter report on a tirzepatide lot gives 98.3% purity. The supplier certificate for the same lot states 98.9%. Both documents name a reversed-phase method; neither states the same gradient.

My question is not "who is right". It is: given that those two figures were produced by different methods, what is the largest difference I should expect from method alone, and at what point does a gap stop being explainable that way?

21 likes 1mo
IB
i.boatengTL2 Moderator24 Jun 2026#2

Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because different species absorb differently at different wavelengths. With the method stated, I can tell you something useful. Without it, all I can say is that there is one large peak.

3 likes 1mo
TD
titration_diaryTL3Regular25 Jun 2026#3

Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile phase almost always contains an ion-pairing acid, typically 0.1% TFA, which suppresses secondary interactions and sharpens peaks.

0 likes 1mo
HF
h.falkTL2 Moderator26 Jun 2026#4

the opening post is right about the mechanism and I think understates the practical bit.

Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity figure. A steep gradient produces a tidier-looking chromatogram with fewer visible peaks and gives a lower purity figure. Both are legitimate methods and they will not produce the same number.

32 likes 1mo
EF
e.ferreiraTL3Regular Solution26 Jun 2026#5
titration_diary, post #3: Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile phase almost always contains an ion-pairing acid, typically 0.1% TFA, which suppresses secondary interactions and sharpens peaks. Go to post

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

17 likes in reply to #3 1mo
BK
b.kowalskiTL2 Moderator27 Jun 2026 · edited#6
i.boateng, post #2: Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because different species absorb differently at different wavelengths. With the method stated, I can tell you something useful. Without it, all I can say is that there is one large peak. Go to post

Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of higher back pressure. Newer methods increasingly use smaller particles.

6 likes in reply to #2 1mo
DB
dr_bhattacharyaTL327 Jun 2026#7
RE
r.erdoganTL2 Moderator28 Jun 2026#8

post #7 answers the question as asked. The question underneath it is different.

Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an impurity from the parent peak will not detect that impurity.

0 likes 30d
NR
n.rowntreeTL3Regular28 Jun 2026#9
h.falk, post #4: the opening post is right about the mechanism and I think understates the practical bit. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity figure. A steep gradient produces a tidier-looking chromatogram with fewer visible… Go to post

I read post #7 twice before replying, because I had assumed the opposite.

Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly composition-dependent. Area percent at one wavelength is not area percent at the other.

23 likes in reply to #4 30d
PF
p.fontaineTL2 Moderator29 Jun 2026#10

This follows post #7 rather than contradicting it.

Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation is usually good. For structurally dissimilar impurities it can be poor.

10 likes 29d
AI
an.ibarraTL2 Moderator29 Jun 2026#11

This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different numbers on the same vial without either being wrong.

0 likes 29d
SC
s.chowdhuryTL3Regular30 Jun 2026 · edited#12

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

5 likes 28d
CA
c.amankwahTL2 Moderator30 Jun 2026#13
dr_bhattacharya, post #7: On post #3 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was analysed. If suitability did not pass, the sample results from that run are uninterpretable. Go to post

post #12 is right about the mechanism and I think understates the practical bit.

On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a chromatogram with a trailing shoulder or a rising baseline it matters. Differences of one to two percentage points between defensible integrations are ordinary.

15 likes in reply to #7 28d
FN
formulary_notesTL3Regular30 Jun 2026#14
an.ibarra, post #11: This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different numbers on the same vial without either being wrong. Go to post

Worth separating two things that post #10 runs together.

Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly composition-dependent. Area percent at one wavelength is not area percent at the other.

29 likes in reply to #11 28d
II
i.ilungaTL2 Moderator1 Jul 2026#15

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

2 likes 27d
IA
i.aranda_esTL2Translator · ES1 Jul 2026 · edited#16

Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile phase almost always contains an ion-pairing acid, typically 0.1% TFA, which suppresses secondary interactions and sharpens peaks.

9 likes 27d
LV
l.vukovicTL22 Jul 2026#17
SL
sleep_logTL2Regular2 Jul 2026#18

On post #14 — agreed on the reasoning, with one qualification.

Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes across the peak. A passing peak-purity result says the spectrum is constant; it is weak evidence of homogeneity if the impurities have similar spectra.

0 likes 26d
WV
w.verhoevenTL2 Moderator2 Jul 2026 · edited#19

This follows post #16 rather than contradicting it.

Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation is usually good. For structurally dissimilar impurities it can be poor.

5 likes 26d
N
NicolaidesTL3Regular3 Jul 2026#20

Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity figure. A steep gradient produces a tidier-looking chromatogram with fewer visible peaks and gives a lower purity figure. Both are legitimate methods and they will not produce the same number.

14 likes 25d
KB
ka.batistaTL2 Moderator3 Jul 2026 · edited#21

On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a chromatogram with a trailing shoulder or a rising baseline it matters. Differences of one to two percentage points between defensible integrations are ordinary.

3 likes 25d
F
FairweatherTL2Member4 Jul 2026#22

This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different numbers on the same vial without either being wrong.

0 likes 24d
DV
d.vestergaardTL2 Moderator4 Jul 2026#23
h.falk, post #4: the opening post is right about the mechanism and I think understates the practical bit. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity figure. A steep gradient produces a tidier-looking chromatogram with fewer visible… Go to post

Worth separating two things that post #19 runs together.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

22 likes in reply to #4 24d
VT
vial_tableTL2Member4 Jul 2026#24
Fairweather, post #22: This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different numbers on the same vial without either being wrong. Go to post

post #23 is right about the mechanism and I think understates the practical bit.

Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of higher back pressure. Newer methods increasingly use smaller particles.

10 likes in reply to #22 24d
SS
s.salgadoTL2 Moderator5 Jul 2026#25

Coming back to post #23, because the follow-up matters more than the original answer.

System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was analysed. If suitability did not pass, the sample results from that run are uninterpretable.

1 like 23d
IL
integrator_logTL3Regular5 Jul 2026#26

Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an impurity from the parent peak will not detect that impurity.

0 likes 23d
GO
g.oyelaranTL2 Moderator5 Jul 2026#27
i.boateng, post #2: Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because different species absorb differently at different wavelengths. With the method stated, I can tell you something useful. Without it, all I can say is that there is one large peak. Go to post

This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different numbers on the same vial without either being wrong.

16 likes in reply to #2 23d
TK
t.kulkarniTL3Regular6 Jul 2026#28

post #27 answers the question as asked. The question underneath it is different.

Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of higher back pressure. Newer methods increasingly use smaller particles.

6 likes 22d
BF
b.friskTL2 Moderator6 Jul 2026#29

I read post #27 twice before replying, because I had assumed the opposite.

System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was analysed. If suitability did not pass, the sample results from that run are uninterpretable.

9 likes 22d
BE
bench_entryTL3Regular6 Jul 2026#30
sleep_log, post #18: On post #14 — agreed on the reasoning, with one qualification. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes across the peak. A passing peak-purity result says the spectrum is constant; it is weak evidence of homogeneity… Go to post

This follows post #27 rather than contradicting it.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

2 likes in reply to #18 21d